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Summary.-C3a was found to be more cytolytic to transformed than to primary
fibroblast cultures from mouse and man. Fibroblasts made quiescent with caffeine
were lysed by the same concentrations of C3a as untreated cells. These findings may
have implications in tumour immunity.
WHEN COMPLEMENT is activated by
either tEe classical or the alternative path-
way, C3 is cleaved into C3a and C3b. C3a
induces the selective release of histamine
from mast cells (Dias da Silva et al., 1967;
Cochrane & Muller-Eberhard, 1968) and
also the contraction of smooth muscle via
histamine release (Bokisch & Muller-
Eberhard, 1970). It has been shown that
macrophages liberate C3a when cultured
in the presence of lipopolysaccharide,
dextran sulphate and C3b (Ferluga et al.,
1978). Purified C3a has been shown to be
cytolytic to a wide variety of cells of both
human and mouse origin (Schorlemmer
et al., 1976; Ferluga et al., 1976, 1978).
Mouse fibroblast lines, lymphnode cells
and the tumour cell line P815 were lysed
at low concentrations of C3a, as were
human cell lines and PHA-stimulated
lymphocytes. C3a caused little lysis of
unstimulated lyAIphocytes. Two possible
interpretations of these results are that
C3a is either more cytolytic to abnormal
cells, or that multiplying cells are more
susceptible than quiescent cells. The pre-
sent experiments were an attempt to
determine which hypothesis is the more
likely, and the results indicate that C3a is
more cytolytic to abnormal than to
normal cells, which may be important in
tumour immunity.
MATERIALS ANI) METHODS
Fibroblast cultures
All fibroblast cell lines were grown in
75cm2 Falcon tissue-culture flasks in medium
supplemented with 10% foetal calf serum
(FCS), penicillin, streptomycin and 20mM
glutamine, and incubated at 37°C in 5°% CO2
until confluent. The monolayers were re-
moved with 0 25% trypsin and cooled on ice
before making dilutions into Falcon 3008
multiwell plates. (All the reagents and
apparatus were obtained from Flow Labs.
Ltd, Irvine, Scotland.)
Human MRC 5 were used at Passage 22,
and were grown in Eagle's MEM. These cells
are a primary line of foetal lung fibroblasts,
and show contact inhibition.
Human adult skin fibroblasts were used at
Passage 20, and were grown in McCoy's
medium. The cells were obtained by skin
biopsy from a patient suffering from general-
ized morphoea and showed contact inhibition.
Mouse NIH 3T3 were used between
Passages 22 and 35, and were grown in
Eagle's MEM. The cells did not demonstrate
good contact inhibition, and grew to a density
greater than 4 x 105 cells/cm2.
Mlurine sarcoma virus-transformed cells
were obtained by infecting NIH 3T3 fibro-
blasts, plated with 5 x 104 cells per 75cm2
flask one day previously, with 2 x 106 foCus-
forming units ofthe Moloney strain of murine
sarcoma virus (MSV). The cells transformed,
and were producing virus at the time of the
C3a assay.
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Hfuman fu S+L- fibroblasts were grown in
McCoy's medium. This amnion cell line has
been transformed with Moloney MSV, but is
non-virus-producing (Peebles et al., 1973).
C3a
The C3a used in the experiments was the
same batch as that used by Ferluga et al.
(1976) and was prepared by Dr Bitter-
Suermann from highly purified C3 (Bitter-
Suermann et al., 1970; Nicholson et al., 1975).
Guinea-pig C3a was prepared by the cleavage
ofpurified C3 by trypsin (1 mg/ml) and, 1 min
later, the reaction was stopped by addition of
soybean trypsin inhibitor (4 mg/ml). The
reaction mixture was passed through a
Sephadex G100 column. The fractions which
mediated contraction of isolated guinea-pig
terminal ileum were pooled and concentrated.
Growth at varying concentrations
Fibroblasts were trypsinized at confluence
and cooled on ice before making serial dilu-
tions (either 1 in 3 or 1 in 4) in ice-cold
medium. Cell dilutions were then dispersed
into multiwell plates containing 1-5 ml
medium and incubated at 37°C in 500 C02
until thehighest cell concentration wasjudged
confluent and the next dilution contained
high cell numbers. The further dilutions
usually gave moderate and sparse growth.
The confluent wells were not used in the
experiments.
Establishment of quiescence by caffeine treat-
ment
Fibroblasts were trypsinized at confluence
and kept on ice until dispensed into multi-
well plates containing 1V5 ml medium. The
wells containing cells to be treated with
caffeine received 10% more cells than control
wells. The plates were incubated at 37°C in
5% CO2 until a moderate growth was
achieved. Fifty00 of the medium was re-
moved, and fresh medium was added con-
taining various concentrations of caffeine, an
adaptation of the method of Pardee & James
(1975). The plates were incubated for 20 h
and the cell monolayer was washed twice.
Some plates were then used for C3a cytolysis,
and others re-incubated to compare DNA
synthesis immediately and 20 h after caffeine
treatment, using 0 02,Ci [14C]TdR as a
measure ofDNA synthesis.
Cytolytic assay
Multiwell plates containing fibroblasts were
incubated for 45 min at 37°C with 5 ,tCi
sodium 51Cr-chromate per well (Radio-
chemical Centre, Amersham) in medium con-
taining 5% FCS. After labelling, cells were
washed twice in medium containing 5% FCS
and twice in serum-free medium. The cells
were then incubated with 120 ,ul of RPMI
1640 medium containing 041% bovine serum
albumin (Sigma Chemical Co. Ltd, Poole) and
various dilutions of C3a. Incubation was at
37°C in a humidified 5%0 C02 atmosphere for
6 h. Medium (0 5 ml) containing 5% FCS was
then added to each well. The supernatant was
removed, and the cells washed once with
380 ,tl medium, which was combined with the
original supernatant to give a total volume of
1 ml for each sample. This was centrifuged
for 10 min at 270 g, and 0 5 ml was removed
for counting the radcioactivity. The cell layer
was treated with trypsin or with 500 Triton
X-100 (BDH Chemicals Ltd, Poole) for 30
min. The cells or cell lysate was then removed
and the wells washed. The cells plus wash
fluid were added to the remaining super-
natant and counted for radioactivity. The
ct/min of the original 0-5ml sample of super-
natant, plus the ct/min of the cells and re-
maining supernatant, represented the total
ct/min in the wells. The cytolysis was then
expressed as
ct/min in0-5ml supernatant x 2
total ct/min
Control wells were trypsinized and the cells
were counted in a haemacytometer to find the
cell numbers at each concentration.
RESULTS
Control experiments on fibroblasts
grown in multiwell plates showed that
treatment with Triton X-100 caused a
51Cr release of 78-84% from the cells,
whereas freezing and thawing the cells
twice caused a 51Cr release of 63-67%0.
When cells were trypsinized and the wells
washed, almost 100% of the 51Cr in the
wells was removed.
Mouse 3T3 fibroblasts, grown in multi-
well plates at varying cell concentrations
and then labelled with 51Cr, were incu-
bated for 6 h in various concentrations of
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TABLE I.-Lysis of 3T3fibroblasts by C3a*
High cell nos.
(2-3-2-5 x 105/well)
69-3 (44 5-80 6)
35-6 (27.7-47-3)
17-1 (13.4-23-7)
12*2 (10.3-14.6)
Moderate cell nos.
(4-6 x 104/well)
69-9 (65 0-79 8)
46-8 (27.5-70 7)
29-6 (19.0-44.2)
18-5 (11-5-22-6)
Low cell nos.
(0.5-1 x 104/well)
59 0 (36.1-75.7)
32-3 (12-2-50-8)
26-5 (20 6-40 3)
18-2 (13-5-23-4)
* As % loss of 51Cr from the cells.
Mean (and range) for 5 wells from 2 experiments.
C3a (Table I). Good cytolysis was obtained
at 5 ug/ml C3a, especially when there
were moderate cell concentrations. It was
thought likely that the cells at moderate
concentrations were growing optimally,
and it was therefore possible that cells
growing more rapidly were more suscept-
ible to C3a.
To test this hypothesis experiments
were performed with caffeine to stop cell
division, an adaptation of the method of
Pardee & James (1975). Cells were incu-
bated with varying concentrations of
caffeine for 19 h. Optimal concentrations
for obtaining quiescence were found to be
in the range of 500 ,ug-1 mg/ml, though
sometimes caffeine proved to be toxic.
This was apparent by microscopic ex-
amination, and the experiment was dis-
carded. Table II shows an experiment
where caffeine was used to inhibit DNA
synthesis in 3T3 cells. Immediately after
removal of caffeine the fibroblasts showed
little incorporation of [14C]TdR, whereas
1 day later they had completely recovered.
TABLE II.-Incorporation of 14C-thymidine
into 3T3 cells after caffeine tredtment
Caffeine
treatment
(Kg/ml)
Nil
700
800
900
1000
2 h pulse
immediately after
caffeine removal
8091 (980)
921 (146)
567 (72)
396 (32)
327 (44)
3 h pulse
20 h after
caffeine removal
13557 (210)
13596 (1764)
12774 (1676)
12642 (654)
11742 (858)
Results of the mean of duplicate wells. The range
is given in brackets.
0 02IC[14C]TdR was added to each well in 1 ml
medium.
The control wells at the end of the experiment
contained 3 x 105 cells.
Mouse MSV-3T3 fibroblasts were grown in
multiwells and treated with various con-
centrations of caffeine. After the removal
of caffeine, some wells were incubated
with [14C]TdR and others were treated
with various C3a concentrations (Table
III). Although TdR incorporation was
inhibited by pre-treatment with caffeine,
showing that the cells were quiescent, the
cytolysis by C3a was similar to that
obtained where no caffeine had been used.
The action of C3a was therefore not
directed specifically at dividing cells.
To determine whether C3a was more
active against transformed than primary
fibroblasts, a comparison was made using
MRC 5 and human adult skin fibroblasts
as the primary lines, and HuS+L- and
MSV-3T3 as the transformed cells. 3T3
cells were considered partially trans-
formed, since they did not show good con-
tact inhibition. All the cell lines were
grown in multiwell plates to give high,
moderate and sparse cell numbers before
treatment with C3a. The 3 cell concentra-
tions all gave similar results, and the
effect of C3a on moderate cell concentra-
tion is shown in Table IV. The primary
human fibroblast lines were not lysed by
concentrations of C3a that were cytolytic
to both the transformed mouse and human
cell lines and to 3T3.
DISCUSSION
The experiments with 3T3 fibroblasts
growing at varying concentrations showed
greater cytolysis on treatment with C3a
when there was a moderate cell concentra-
tion, which implied that cells growing
C3a
concentration
(Cg/ml)
10
5
2-5
Nil
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TABLE III. Effect of quiescence on lysis on MSV-3T3 fibroblasts by C3a
C3a
concentration
(Kg/ml)
10
5
2-5
Nil
[14C]TdR
incorporation
C-
Nil
4 x 105/well
69-0 (7 6)
40-9 (1-6)
29-5 (1-4)
15-9 (1-6)
11638 (1922)
Caffeine pretreatment
500 ,ug/ml 700 Hg/ml
3 x 105/well 3 x 105/well
57-2 (17-0)
47 0 (0.2)
35-5 (1-8)
20-3 (0 2)
1395 (50)
65-4 (0 6)
52-2 (3 4)
31-3 (3:4)
23 4 (0 2)
657 (170)
900 Hg/m1
2-5 x 105/well
67-3 (0 6)
54-3 (2 6)
33-4 (1-0)
27-2 (2.0)
294 (20)
Results are the mean of duplicate wells. The range is given in brackets.
Lysis is expressed as 00 loss of 51Cr.
0-02 HtC[ 4C]TdR was incubated with control cultures in I ml for 3 h.
TABLE IV.-Lysis by C3a of various fibroblast lines
C3a
coincentration Human adult skin
(Kg/ml) 1-3 x 105/well
MRC 5 HuS+L- 3T3 MSV-3T3
9 X 104/well 9 X 104/well 5 x 104/we11 5 x 104/well
44-6 (33 5-54 2)
14-4 (12-5-15-9)
7-1 (6-2-7.9)
5-8 (4.8-64)
20-7 (16-8-24-6)
24-5 (16.0-32-4)
12-9 (12-4-12-9)
10-5 (101-11.1)
NT
732 (72-1-74-3)
29-0 (28.3-29-7)
12-7 (11-6-13-7)
NT
69-9 (65-0-79-8)
46-8 (27.5-70 7)
18-5 (11-5-22-6)
NT
83-3
72-3 (67 3-77.3)
23-0 (19-7-25-1)
Lysis is expressed as % loss of 51Cr from the cells.
Results are the mean of triplicate cultures except for 3T3 which is the mean of 5 cultures and MSV-3T3
which is the mean ofduplicate cultures.
The range is given in brackets.
NT: not tested.
optimally were more susceptible to C3a.
However, when cells were pre-treated
with caffeine, the results showed clearly
that quiescent fibroblasts were as suscept-
ible to C3a as rapidly dividing cells.
The comparison of several abnormal
and primary cell lines showed that the
primary human fibroblast lines MRC 5
and adult skin fibroblasts were more
resistant to lysis by C3a than were MSV-
transformed mouse fibroblasts and MSV-
transformed human amnion cells. The
human HuS+L- cells did not produce
virus, whereas the MSV-3T3 cells were
producing virus at the time of the experi-
ment. These experiments show that C3a
is more cytolytic to abnormal than to
normal cells. These findings are in agree-
ment with those of Ferluga et al. (1976).
Many workers have shown that cell-
surface changes are associated with trans-
formation and malignancy (review article
by Nicholson, 1976). Transformed cells
agglutinate with lectins more readily than
normal cells, show greater membrane
motility and demonstrate new antigens on
their surface, such as tumour-associated
antigens, virus antigens and Forssman
antigen. It is possible that C3a attacks via
a site which is more available on trans-
formed cells.
Earlier work by Lai A Fat & Van Furth
(1975) and by Bentley et al. (1976) has
demonstrated that macrophages can syn-
thesize C3, and Schorlemmer & Allison
(1976) showed that activated macrophages
release enzymes capable of C3 cleavage.
Ferluga et al. (1978) showed that activated
macrophages killed tumour cells and
liberated C3a into the medium. Since the
present experiments have shown that C3a
is more cytolytic to abnormal than to
normal cells, this may prove important
as a mechanism in tumour rejection.
Wuepper et al. (1972) showed that 20ng
C3a caused an inflammatory reaction when
15
10
5
Nil
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injected into guinea-pig skin, so that it is
unlikely that the concentrations of C3a
used in the present experiments would be
found circulating in vivo. However, it is
possible that C3a generated by the action
of macrophage enzymes on C3 could pro-
duce local concentrations ofthe order used
in these experiments.
We would like to thank Dr H. U. Scliorlemmer
and Dr Bitter-Suermann, Institute of Medical
Microbiology, Univers'ty of Mainz, Germany, for
kindly providing the C3a, Dr J. Harvey forsupplying
Hu S+L-, 3T3 and MSV-3T3 cells and Mr P. Narcissi
for supplying the human adult fibroblasts.
REFERENCES
BENTLEY, C., BITTER-SUERMANN, D., HAI)DING, U.
& BRADE, V. (1976) In vitro syntbesis of factor B
of the alternative pathway ofcomplement activa-
tionby mouseperitonealmacropbages. Eur. J. Im-
munol., 6, 393.
BITTER-SUERMANN, D., HADDING, U., MELCHERT, F.
& WELLENSIEK, H. J. (1970) Independent and
consecutive action of the complement components
C5, C6 and C7 in immune haemolysis. 1: Prepara-
tion of EAC 1-5 with purified guinea pig C3 and
C5. Immunochemi-stry, 7, 955.
BOKISCH, V. A. & MtLLER-EBERHARD, H. J. (1970)
Anaphylatoxin inactivator of human plasma: its
isolation and characterization as a carboxy-
peptidase. J. Clin. Invest.,49, 2427.
COCHRANE, C. G. & Mt.LLER-EBERHARD, H. J.
(1968) The derivation of two distinct anaphyla-
toxin activities from the third and fifth com-
ponents of human complement. J. Exp. Med.,
127, 371.
DIAS DA SILVA, W., EISELE, J. W. & LEPOW, 1. H.
(1967) Complement as a mediator ofinflammation.
III Purification of the activity withanaphylatoxin
properties generated by interaction of the first
four components ofcomplement and its identifica-
tion as a cleavage product of C'3. J. Exp. Med.,
126, 1027.
FERLUGA, J., SCHORLEMMER, H. U., BAPTISTA, L. C.
& ALLISON, A. C. (1976) Cytolytic effects of the
complement cleavage product, C3a. Br. J. Cancer,
34, 626.
FERLUGA, J., SCHORLEMMER, H. U., BAPTISTA, L. C.
& ALLISON, A. C. (1978) Production of the comple-
ment cleavage product, C3a, by activated macro-
phages and its tumorolytic effects. Clin. Exp.
Immunol., 31, 512.
GoODMAN, M., WEIGLE, W. 0. & HuGLI, T. E. (I980)
Inability of the C3a anaphylatoxin to promote
cellular lysis. Nature, 283, 78.
LAi A FAT, R. F. & VAN FURTH, R. (1975) It? vitro
synthesis of some complement components
(Clq, C3 and C4) by lymphoid tissues and circu-
lating leucocytes in man. Immunology, 28, 359.
NiCHOLSON, A., BRADE, V., SCHORLEMMER, H. U.,
BURGER, R., BITTER-SUERMANN, D. & HADDING,
U. (1975) Interaction of C3b. B and D in the
alternative pathway of complement, activation.
J. Immunol., 115,1108.
NICHOLSON, G. L. (1976) Trans-membrane control of
the receptors of normal and tumour cells. 11:
Surface changes associated with transformation
andmalignancy. Biochim. Biophys. Acta,458, 1.
PARDEE, A. B. & JAMES, L. J. (1975) Selective killing
of transformed baby hamster kidney (BHK) cells.
Proc. Natl Acad. Sci., U.S.A., 72, 4994.
PEEBLES, P. T., FiSCHINGER, P. J., BASSIN, R. H.
& PAPAGEORGE, H. F. (1973) Isolation of human
amnioii cells transformed by rescuable murine
sarcome virus. Nature (New Biol.),242, 98.
SCHORLEMMER, H. U. & ALLISON, A. C. (1976).
Effects of activated complement components on
enzyme secretion by macrophages. Immunology,
31, 781.
SCHORLEMMER, H. U., DAVIES, P. & ALLISON, A. C.
(1976) Ability of activated complement compo-
nents to induce lysosomal enzyme release from
macrophages. Nature, 261, 48.
WUEPPER, K. D., BOKISCH, V. A., Mi:TLLER-EBER-
HARD, H. J. & STOUGHTON, R. B. (1972) Cutaneous
responses to human C3 anaphylatoxin in man.
Clin. Exp. Immunol., 11, 13.
ADDENDUM
After thismanuscript had beenaccepted
Goodman et al. (1980) reported that they
were unable to promote cellular lysis by
Oa. We have compared their Oa, a gift
from Dr Hugli to Dr Allison, with the
C3a from Dr Schorlemmer, using 3T3
fibroblasts as target cells. Cytolysis, ex-
pressed as % 51Cr release after 7 h at 370C
was C3a (Hugli) 5 .ug/ml, 52-9 + 0-3;
C3a (Schorlemmer) 5 .ug/ml, 42-8 + 0-1.
Spontaneous release under the same
conditions was 10-8+0-1. These results
show that in our experiments the C3a
from Dr Hugli's laboratory is at least
ascytolytic as that from Dr Schorlemmer.
We. have no explanation at this time for
the discrepancy between our results and
those of Goodman et al.